Gregg Williams Buys 34,000 Shares of Vivani Medical, Inc. (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired 34,000 shares of the stock in a transaction on Friday, April 4th. The shares were purchased at an average price of $0.99 per share, for a total transaction of $33,660.00. Following the completion of the transaction, the director now owns 4,754,800 shares in the company, valued at approximately $4,707,252. This represents a 0.72 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

Gregg Williams also recently made the following trade(s):

• On Monday, April 7th, Gregg Williams purchased 44,400 shares of Vivani Medical stock. The shares were acquired at an average price of $0.99 per share, for a total transaction of $43,956.00.
• On Wednesday, April 2nd, Gregg Williams acquired 2,000 shares of Vivani Medical stock. The stock was acquired at an average cost of $1.01 per share, with a total value of $2,020.00.

Vivani Medical Trading Down 3.8 %

NASDAQ VANI opened at $1.01 on Friday. Vivani Medical, Inc. has a 1-year low of $0.91 and a 1-year high of $2.09. The firm’s fifty day simple moving average is $1.10 and its 200-day simple moving average is $1.19. The company has a market capitalization of $59.83 million, a PE ratio of -2.24 and a beta of 2.76.

Vivani Medical (NASDAQ:VANI) last issued its earnings results on Monday, March 31st. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.01). As a group, analysts predict that Vivani Medical, Inc. will post -0.41 EPS for the current year.

Hedge Funds Weigh In On Vivani Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its stake in shares of Vivani Medical by 4.6% during the 3rd quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock worth $401,000 after purchasing an additional 15,008 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of Vivani Medical in the 4th quarter valued at $66,000. Northern Trust Corp boosted its holdings in Vivani Medical by 19.1% in the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock worth $83,000 after purchasing an additional 11,540 shares in the last quarter. Finally, Wealthedge Investment Advisors LLC acquired a new position in Vivani Medical during the fourth quarter worth $43,000. Institutional investors own 6.78% of the company’s stock.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 target price on shares of Vivani Medical in a research note on Friday, April 4th.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.